Several points relevant to neurology were discussed during a special session on TBI by the Association for Research in Vision and Ophthalmology.
© Chaiwut Siriphithakwong/Shutterstock.com
The Physiology of Nightmares
New research reveals the presence of physiological changes in research participants while suffering from bad dreams.
Anticoagulation in Afib Patients on Dialysis
Can anticoagulation harm patients with atrial fibrillation who are on dialysis? Results from a meta-analysis may surprise you.
Neuro News Roundup: Stroke Update
Three studies regarding stroke look at blood pressure trajectories, use of occlusion, and the advantage of conscious sedation over general anesthesia.
Driving with Cognitive Impairment
Investigators questioned whether cognitive tests could predict driving ability in people with Alzheimer disease and mild cognitive impairment.
Exploratory Trial for Essential Tremor Treatment
In a proof-of-concept study, 25 patients were exposed to a dose-escalating infusion of SAGE-547 to evaluate the drug’s effect on essential tremor.
Does a Busy Lifestyle Improve Memory?
Did an active schedule help or hinder cognitive skills such as memory, reasoning, and crystallized knowledge in a group of adults aged 50-89 years?
Modeling Simulations to Predict AED Efficacy
Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).
Potential Treatment for SRSE
Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.
Asymptomatic Carotid Stenosis: How to Treat?
In this Medical News Minute, Dr Bobby Lazzara examines carotid-artery stenting vs. carotid endarterectomy to treat asymptomatic carotid stenosis.
Neuro News Roundup: Consequences of Neuro Conditions
Neurologic conditions, such as epilepsy, migraine, and stroke, often have real-world consequences, such as those described in three new studies.
Interesting Neuro: Alzheimer & Parkinson insights
Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.
Clinical Trial Highlights: AAN 2016 – Part 1
From no evidence of disease activity in MS to studies of a new treatment for periodic paralysis, AAN 2016 featured many exciting clinical trials.
By clicking Accept, you agree to become a member of the UBM Medica Community.